Brand & Product Security

Videos

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, comments on what the repercussions are for failing to comply with the DSCSA.

Consequences of Non-Compliance 

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, describes the latest state of DSCSA implementation guidelines.

Navigating DSCSA Delays

Podcasts

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Nov. 27 is Here: What Does That Mean for DSCSA?

Articles

The proposal aims to reduce out-of-pocket costs for a number of weight loss medications by 95%.

Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Weight Loss Medications

Why well-organized documentation is critical at every stage of the process.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.

Key Challenges Facing the Pharma Industry in 2025

In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.

Peer Exchange: An Overview of RFID Within the Pharmaceutical Industry (Episode 1)

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.

Understanding the FDA's Exemption for DSCSA Compliance

In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications. 

Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In

Albert Thigpen, co-founder, Talentwise Consulting, discusses the valuable buckets pertaining to the PBM space. 

Legal & Regulatory